By incorporating multiple ML algorithms, we also identified several biomarker genes that can distinguish hot tumors from cold tumors and predict PAAD prognosis, including ITGB4, PLEC, TRPV1, AHNAK2, CEP295NL, and POLQ (Fig. 7A–C). This evidence concerns the gene CEP295NL and pancreatic adenocarcinoma.